Macrophage Diversity Enhances Tumor Progression and Metastasis

被引:4200
作者
Qian, Bin-Zhi [1 ]
Pollard, Jeffrey W. [1 ,2 ,3 ]
机构
[1] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Cooperat Ctr Study Reprod & Infertil Res, Bronx, NY 10461 USA
基金
美国国家卫生研究院;
关键词
COLONY-STIMULATING FACTOR; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; GENE-EXPRESSION ANALYSIS; LYMPH-NODE METASTASIS; MYELOID CELLS; PROMOTE TUMOR; MOUSE MODEL; ANGIOGENIC SWITCH;
D O I
10.1016/j.cell.2010.03.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is persuasive clinical and experimental evidence that macrophages promote cancer initiation and malignant progression. During tumor initiation, they create an inflammatory environment that is mutagenic and promotes growth. As tumors progress to malignancy, macrophages stimulate angiogenesis, enhance tumor cell migration and invasion, and suppress antitumor immunity. At metastatic sites, macrophages prepare the target tissue for arrival of tumor cells, and then a different subpopulation of macrophages promotes tumor cell extravasation, survival, and subsequent growth. Specialized subpopulations of macrophages may represent important new therapeutic targets.
引用
收藏
页码:39 / 51
页数:13
相关论文
共 131 条
[1]   Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma [J].
Abraham, Dietmar ;
Zins, Karin ;
Sioud, Mouldy ;
Lucas, Trevor ;
Schaefer, Romana ;
Stanley, E. Richard ;
Aharinejad, Seyedhossein .
INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (06) :1339-1352
[2]  
Aharinejad Seyedhossein, 2009, V487, P243, DOI 10.1007/978-1-60327-547-7_12
[3]   Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice [J].
Almholt, K ;
Lund, LR ;
Rygaard, J ;
Nielsen, BS ;
Dano, K ;
Romer, J ;
Johnsen, M .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (04) :525-532
[4]   Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer [J].
Bailey, Charles ;
Negus, Rupert ;
Morris, Alistair ;
Ziprin, Paul ;
Goldin, Robert ;
Allavena, Paola ;
Peck, David ;
Darzi, Ara .
CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (02) :121-130
[5]   Smoldering and polarized inflammation in the initiation and promotion of malignant disease [J].
Balkwill, F ;
Charles, KA ;
Mantovani, A .
CANCER CELL, 2005, 7 (03) :211-217
[6]   Tumour necrosis factor and cancer [J].
Balkwill, Frances .
NATURE REVIEWS CANCER, 2009, 9 (05) :361-371
[7]   The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma [J].
Beck, Andrew H. ;
Espinosa, Inigo ;
Edris, Badreddin ;
Li, Rui ;
Montgomery, Kelli ;
Zhu, Shirley ;
Varma, Sushama ;
Marinelli, Robert J. ;
van de Rijn, Matt ;
West, Robert B. .
CLINICAL CANCER RESEARCH, 2009, 15 (03) :778-787
[8]   Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].
Berg, DJ ;
Davidson, N ;
Kuhn, R ;
Muller, W ;
Menon, S ;
Holland, G ;
ThompsonSnipes, L ;
Leach, MW ;
Rennick, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020
[9]   The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [J].
Bingle, L ;
Brown, NJ ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :254-265
[10]   A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation) [J].
Biswas, SK ;
Gangi, L ;
Paul, S ;
Schioppa, T ;
Saccani, A ;
Sironi, M ;
Bottazzi, B ;
Doni, A ;
Vincenzo, B ;
Pasqualini, F ;
Vago, L ;
Nebuloni, M ;
Mantovani, A ;
Sica, A .
BLOOD, 2006, 107 (05) :2112-2122